Nextki 50mg Tablet

Discover how Nextki 50mg Tablet, formulated by Emcure Pharmaceuticals Ltd with Dasatinib (50mg), can assist with Blood cancer (Chronic myeloid leukaemia). This page provides a comprehensive overview of this medication, including its primary applications and further detailed information to support your understanding. Feel free to add it to your favorites or compare it with other available options.

MRP: ₹ 3500
Packing: 60.0 tablets in 1 strip
Salt Combination: Dasatinib (50mg)
Brand: Emcure Pharmaceuticals Ltd
Uses: Blood cancer (Chronic myeloid leukaemia)

Description

Nextki 50mg Tablet is used in the treatment of blood cancer (chronic myeloid leukaemia)
It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects
Nextki 50mg Tablet can be taken with or without food, but try to have it at the same time every day to get the most benefits
Your doctor will decide what dose is necessary and how often you need to take it
This will depend on what you are being treated for and may change from time to time
You should take it exactly as your doctor has advised
Taking it in the wrong way or taking too much can cause very serious side effects
It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Nausea, vomiting, abdominal pain and rash are some common side effects of this medicine
In some cases, it may cause increased heartbeat and low or high blood pressure, if it happens consult with your doctor
Your doctor might check your blood pressure regularly
It is advised to avoid antacid intake within 2 hours of taking this medicine
This medicine may reduce the number of blood cells in your blood, thereby, increasing the susceptibility to infections
Regular blood tests are required to check your blood cells.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using
This medicine is not recommended during pregnancy or while breastfeeding
You must avoid driving if you experience dizziness or blurred vision during treatment.

Cautions

Liver:	SAFE IF PRESCRIBED: Nextki 50mg Tablet is safe to use in patients with liver disease. No dose adjustment of Nextki 50mg Tablet is recommended.
Kidney:	SAFE IF PRESCRIBED: Nextki 50mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nextki 50mg Tablet may not be needed in these patients. Please consult your doctor.
Driving:	UNSAFE: Nextki 50mg Tablet may cause side effects which could affect your ability to drive.^Take special care when driving in case you experience side effects such as dizziness and blurred vision with Nextki 50mg Tablet.
Breast feeding:	UNSAFE: Nextki 50mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnency:	CONSULT YOUR DOCTOR: Nextki 50mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Alcohol:	CONSULT YOUR DOCTOR: It is not known whether it is safe to consume alcohol with Nextki 50mg Tablet. Please consult your doctor.
Drug Action:	Tyrosine kinase inhibitors
Therapeutic class:	ANTI NEOPLASTICS
Habit Forming:	No
Chemical Class:	Pyrimidine and Thiazole Derivetive